Treats gingivitis as characterized. Sold as Hibiclens, Hibistat, Peridex, Dyna-Hex 4, Exidine and 8 more. Every FDA application for this active ingredient: 16 branded and 16 generic.
As of Nov 15, 2026, FDA lists 32 applications for Chlorhexidine Gluconate (sold as Hibiclens, Hibistat, Peridex and others), first approved Sep 17, 1976, with 4 new uses approved and 0 published complete response letters.
| Chlorhexidine Gluconate | Part D | $15.3M | +12% | 1,713,834 |
| Periogard | Part D | $31K | +33% | 4,654 |
| Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsDiabetic Foot Disease, Foot Ulcer Due to Type 1 Diabetes Mellitus · Cutempa Medical AG | Not applicable | Recruiting | Nov 13, 2026 |
| Ultrasound-Guided Percutaneous Electrolysis Plus Exercise for Chronic Supraspinatus TendinopathySupraspinatus Tendinopathy, Rotator Cuff Tendinopathy · DAVID CRUZ DÍAZ | Not applicable | Enrolling by invitation | Nov 10, 2026 |
| Ozone Gel Versus Chlorohexidine Gel as an Adjunct to Non-Surgical Treatment of Stage II Periodontitis Grade B Among Smokers PatientsOzone Gel, Chlorohexidine Gel · October 6 University | Not applicable | Recruiting | Nov 6, 2026 |
| Soap-and-Water Bed Bath Versus Disposable Wipe Bath in the Same ICU PatientsCritical Illness, Pain · Sinop Atatürk State Hospital | — | Not yet recruiting | Nov 5, 2026 |
| Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot StudyTooth Loss and Rehabillitation, Dental Implant Failure · University of Medicine and Pharmacy at Ho Chi Minh City | Not applicable | Not yet recruiting | Nov 5, 2026 |
| A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After MastectomyBreast Cancer, Breast Cancer Female · Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Nov 5, 2026 |
| Efficacy of Thymus Vulgaris Mouthwash in the Management of Biofilm-Induced GingivitisPlaque-Induced Gingivitis · University of Sulaimani | Phase 2 | Not yet recruiting | Oct 29, 2026 |
| Oral Mucosal Grafting for Nasal Septal Perforation RepairNasal Septal Perforation · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | — | Not yet recruiting | Oct 29, 2026 |
| Sep 17, 1976 | HibiclensNDA 17768 · New active ingredient | Molnlycke Hlth | 39 | Marketed |
| May 23, 1980 | HibistatNDA 18300 · New dosage form | Molnlycke Hlth | 17 | Marketed |
| Aug 27, 1981 | HibiclensNDA 18423 · New formulation or manufacturer | Molnlycke Hlth | 13 | Discontinued |
| Dec 24, 1984 | Dyna-Hex 4NDA 19125 · New dosage form | Xttrium | 27 | Marketed |
| Dec 24, 1984 | ExidineNDA 19127 · New dosage form | Xttrium | 13 | Marketed |
| Dec 17, 1985 | ExidineNDA 19421 · New dosage form | Xttrium | 1 | Discontinued |
| Dec 17, 1985 | Dyna-Hex 2NDA 19422 · New dosage form | Xttrium | 34 | Marketed |
| Jul 22, 1986 | Cida-Stat, Chg ScrubNDA 19258 · New formulation or manufacturer | Ecolab | 17 | Marketed |
| Jul 24, 1986 | Steri-StatANDA 70104 | Matrix Medcl | 3 | Discontinued |
| Aug 13, 1986 | PeridexNDA 19028 · New dosage form | Solventum | 15 | Marketed |
| Dec 17, 1987 | Brian CareANDA 71419 | Soapco | 9 | Discontinued |
| Dec 2, 1988 | Pharmaseal Scrub CareNDA 19793 · New formulation or manufacturer | Carefusion 2200 | 3 | Discontinued |
| Mar 31, 1989 | BioscrubNDA 19822 · New formulation or manufacturer | Griffen | 5 | Marketed |
| Oct 24, 1989 | Chlorhexidine GluconateANDA 72525 | Becton Dickinson | 0 | Marketed |
| Feb 28, 1991 | MicrodermANDA 72295 | J And J | 0 | Discontinued |
| Apr 15, 1991 | MicrodermANDA 72255 | J And J | 5 | Discontinued |
| Jan 28, 1992 | Prevacare RANDA 72292 | J And J | 5 | Discontinued |
| Jan 14, 1994 | PeriogardANDA 73695 | Colgate Palmolive Co | 13 | Discontinued |
| Dec 15, 1995 | Chlorhexidine GluconateANDA 74522 | Pharm Assoc | 13 | Marketed |
| Dec 28, 1995 | Chlorhexidine GluconateANDA 74291 | Lyne | 4 | Marketed |
| May 7, 1996 | Chlorhexidine GluconateANDA 74356 | Sciegen Pharms | 5 | Discontinued |
| Sep 11, 1997 | Chlorhexidine GluconateNDA 20111 · New dosage form | Bajaj | 5 | Marketed |
| May 15, 1998 | PeriochipNDA 20774 · New dosage form | Dexcel Pharma | 10 | Discontinued |
| Mar 14, 2000 | E-Z ScrubANDA 73416 | Becton Dickinson | 0 | Discontinued |
| Nov 14, 2000 | Chlorhexidine GluconateANDA 75561 | Bajaj | 5 | Marketed |
| Mar 3, 2004 | Chlorhexidine GluconateANDA 75006 | Chartwell Rx | 0 | Marketed |
| Apr 25, 2005 | Chlorhexidine GluconateNDA 21669 · New dosage form | Sage Prods | 13 | Marketed |
| Nov 29, 2005 | ParoexANDA 76434 | Sunstar Americas | 1 | Discontinued |
| Jun 18, 2009 | Chlorhexidine GluconateANDA 77789 | Pharmobedient | 2 | Marketed |
| Jan 28, 2016 | PeriogardANDA 203212 | Colgate-Palmolive Co | 1 | Marketed |
| Nov 20, 2018 | Readyprep ChgNDA 207964 · New formulation or manufacturer | Medline Industries | 1 | Marketed |
| — | Chlorhexidine GluconateNDA 19490 | Kendall Il | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA